Bile Acid Sequestrant [EPC]

Known as: Bile Acid Sequestrant 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1961-2017
02419612017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
The primary aim of this completed multicentre randomised, parallel, double-blind placebo-controlled study was to elucidate the… (More)
  • figure 1
  • table 1
  • figure 3
  • table 2
  • figure 4
Is this relevant?
2010
2010
Vibrio parahaemolyticus, a bacterial pathogen, causes human gastroenteritis. A type III secretion system (T3SS2) encoded in… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
Is this relevant?
2010
2010
UNLABELLED Colesevelam is an anion-exchange resin with a 7-fold higher bile acid-binding capacity and fewer side effects than… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2010
2010
Cholestyramine is a first-generation bile acid sequestrant (BAS) and antihyperlipidemic agent that currently has limited use… (More)
Is this relevant?
2010
2010
An improved ultra performance liquid chromatography-tandem mass spectrometry (UPLC/MS/MS) method was established for the… (More)
  • figure 1
  • table 2
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2010
2010
The bile acid sequestrant, colesevelam hydrochloride, is approved for glycemic control in adults with type 2 diabetes. In three… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2005
2005
OBJECTIVE The aim of this study was to evaluate the amount of low-density lipoprotein cholesterol (LDL-C) reduction achieved by… (More)
Is this relevant?
1994
1994
OBJECTIVE Noxious adverse effects frequently limit patient acceptance of niacin and bile acid sequestrants (BAS), first-line… (More)
Is this relevant?
1972
1972
Nachweis, dass die Gallensalze an der Entstehung des gastrointestinalen Strahlensyndroms mitverantwortlich sind und dass DEAE… (More)
  • figure 1
Is this relevant?
1961